Patanjali misleading ads case: Kerala court summons Baba Ramdev and Acharya Balkrishna

A Kerala Court has directed Patanjali Ayurved Co-founder Baba Ramdev and its Managing Director Acharya Balkrishna to appear before it on June 03, 2024 in a case of publishing misleading advertisements in English and Malayalam newspapers.

By  Storyboard18May 23, 2024 8:32 AM
Patanjali misleading ads case: Kerala court summons Baba Ramdev and Acharya Balkrishna
Baba Ramdev’s Patanjali has been under scrutiny for issuing misleading advertisements for health cures. Last month, the Supreme Court lambasted both Ramdev and Acharya Balkrishna of Patanjali for advertisements that promoted the Ayush treatment system while undermining modern, evidence-based medicine and asked them to tender a public apology.

Yoga guru Baba Ramdev and his associate Acharya Balkrishna have been asked to appear before the Judicial First Class Magistrate Court in Kozhikode on June 3 in a case related to placing misleading advertisements in English and Malayalam newspapers. Both are founders of Haridwar-based Divya Pharmacy that markets Patanjali Ayurved’s products; Acharya Balkrishna is also its Managing Director.

This comes after the Drugs Inspector, Office of the Assistant Drugs Controller, Kozhikode filed a complaint in Kozhikode Court against Divya Pharmacy. The case has been filed under Section 3 of The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. Section 3 prohibits the advertisement of certain drugs for the treatment of certain diseases and disorders.

The specific allegation was misleading advertisements were published claiming that “Divya Lipdom” tablet manufactured by Divya Pharmacy claimed to reduce abnormal levels of cholesterol and fat in the body and to improve fat metabolism. And, the product “Nutrella Diabetic Care” manufactured by Patanjali Ayurved claims to manage blood sugar levels and body weight.

Baba Ramdev’s Patanjali has been under scrutiny for issuing misleading advertisements for health cures. Last month, the Supreme Court lambasted both Ramdev and Acharya Balkrishna of Patanjali for advertisements that promoted the Ayush treatment system while undermining modern, evidence-based medicine and asked them to tender a public apology.

After issuing the apology, the duo later asked the SC for time to file affidavit regarding steps taken to recall advertisement for medicines for which the company’s license was revoked. The SC granted them a period of three weeks.

First Published on May 23, 2024 8:32 AM

More from Storyboard18

Brand Marketing

Meta to fully automate advertising with AI by end of 2026

Meta to fully automate advertising with AI by end of 2026

Brand Marketing

Starbucks is offering Rs 3 crore salary for new role. More details inside

Starbucks is offering Rs 3 crore salary for new role. More details inside

Brand Makers

FIR filed against Virat Kohli’s One8 Commune in Bengaluru for smoking zone violation

FIR filed against Virat Kohli’s One8 Commune in Bengaluru for smoking zone violation

Brand Marketing

Air India revamps workforce, lowers average cabin crew age to 29

Air India revamps workforce, lowers average cabin crew age to 29

Brand Makers

Maruti Suzuki's PV sales declined by 5.5% in May; Alto, S-Presso witness 31.5% drop

Maruti Suzuki's PV sales declined by 5.5% in May; Alto, S-Presso witness 31.5% drop

Brand Makers

EaseMyTrip launches 2.0, targets high-growth travel firms with 49% investment

EaseMyTrip launches 2.0, targets high-growth travel firms with 49% investment

How it Works

Maharashtra FDA suspends Zepto's food license over safety violations

Maharashtra FDA suspends Zepto's food license over safety violations

Brand Marketing

Beyond Bras! Enamor to launch new brand avatar in October to target GenZ

Beyond Bras! Enamor to launch new brand avatar in October to target GenZ